These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33082934)

  • 1. Evidence for adverse effects of cannabidiol (CBD) products and their non-conformity on the European food market - response to the European Industrial Hemp Association.
    Lachenmeier DW; Walch SG
    F1000Res; 2020; 9():1051. PubMed ID: 33082934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on Lachenmeier
    Kruse D; Beitzke B
    F1000Res; 2020; 9():900. PubMed ID: 32864108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
    Lachenmeier DW; Habel S; Fischer B; Herbi F; Zerbe Y; Bock V; Rajcic de Rezende T; Walch SG; Sproll C
    F1000Res; 2019; 8():1394. PubMed ID: 32117565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products.
    Zamarripa CA; Tilton HE; Lin S; Cone EJ; Winecker RE; Flegel RR; Kuntz D; Beals M; Jacques M; Clark M; Welsh ER; Wagner L; Bonn-Miller MO; Vandrey R; Spindle TR
    J Anal Toxicol; 2024 Mar; 48(2):81-98. PubMed ID: 38217086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Trends of Tetrahydrocannabinol (THC) in a 2008-2021 German National Survey of Hemp Food Products.
    Dräger H; Barthlott I; Golombek P; Walch SG; Lachenmeier DW
    Foods; 2022 Feb; 11(3):. PubMed ID: 35159636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products.
    Meng Q; Buchanan B; Zuccolo J; Poulin MM; Gabriele J; Baranowski DC
    PLoS One; 2018; 13(5):e0196396. PubMed ID: 29718956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman-Based Differentiation of Hemp, Cannabidiol-Rich Hemp, and Cannabis.
    Sanchez L; Baltensperger D; Kurouski D
    Anal Chem; 2020 Jun; 92(11):7733-7737. PubMed ID: 32401504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements.
    Wakshlag JJ; Cital S; Eaton SJ; Prussin R; Hudalla C
    Vet Med (Auckl); 2020; 11():45-55. PubMed ID: 32346530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Hemp as Food and Nutritional Supplement.
    Cerino P; Buonerba C; Cannazza G; D'Auria J; Ottoni E; Fulgione A; Di Stasio A; Pierri B; Gallo A
    Cannabis Cannabinoid Res; 2021; 6(1):19-27. PubMed ID: 33614949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol (CBD) product contamination: Quantitative analysis of Δ
    Johnson E; Kilgore M; Babalonis S
    Drug Alcohol Depend; 2022 Aug; 237():109522. PubMed ID: 35690015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicians' Guide to Cannabidiol and Hemp Oils.
    VanDolah HJ; Bauer BA; Mauck KF
    Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science.
    Marinotti O; Sarill M
    J Diet Suppl; 2020; 17(5):517-526. PubMed ID: 32543253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Cannabidiol, Δ
    ElSohly MA; Murphy TP; Khan I; Walker LW; Gul W
    Med Cannabis Cannabinoids; 2020 Aug; 3(1):1-13. PubMed ID: 34676337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 16. Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland.
    Grafinger KE; Krönert S; Broillet A; Weinmann W
    Forensic Sci Int; 2020 May; 310():110261. PubMed ID: 32229319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
    Brighenti V; Protti M; Anceschi L; Zanardi C; Mercolini L; Pellati F
    J Pharm Biomed Anal; 2021 Jan; 192():113633. PubMed ID: 33039911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.
    Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA
    Front Public Health; 2022; 10():893009. PubMed ID: 35784239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature.
    Golombek P; Müller M; Barthlott I; Sproll C; Lachenmeier DW
    Toxics; 2020 Jun; 8(2):. PubMed ID: 32503116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
    Koturbash I; MacKay D
    J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.